Kris G. Samsom

The Netherlands Cancer Institute

Papers

1

Total Citations

86

H-Index

1

About

Dr. Kris G. Samsom is a leading figure in precision oncology, whose work centers on the clinical implementation of comprehensive genomic profiling for cancer diagnostics. His most impactful contribution is the clinical validation of whole genome sequencing (WGS) as a single, all-inclusive test for cancer patients. In his landmark 2021 study, cited over 80 times, Dr. Samsom demonstrated that WGS using fresh-frozen tissue and matched blood samples can serve as a complete genetic tumor test, effectively replacing the need for multiple, sequential assays. This work directly addresses a critical bottleneck in modern oncology: the increasing number of biomarkers to screen from ever-smaller biopsy samples. By advocating for a unified WGS approach, he has provided a scalable, future-proof framework for cancer diagnostics. His research is instrumental in moving the field beyond targeted panels, paving the way for more comprehensive, cost-effective, and data-rich tumor characterization that can guide personalized treatment decisions for every patient.

Research Focus

Key Achievements

1
H-Index
1
Papers
86
Total Citations
86
Avg Citations/Paper
🏆 Most Cited Paper
Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics
86 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: The Netherlands Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago